Found 34 matching trials
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer PHASE2 Study design: Prospective, single-arm, single-center phase II clinical stud...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients NA This is a prospective study to evaluate the safety and efficacy of Sintilim...
Show More Location
the Fifth Medical Center, Chinese PLA General Hospital
Learn More & Join Trial
Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma PHASE2 This is a single-arm phase II clinical trial to evaluate the initial effica...
Show More Location
West China Hospital
Learn More & Join Trial
HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis PHASE2 The prognosis of patients with peritoneal metastasis from gastric cancer is...
Show More Location
Multiple Locations
Learn More & Join Trial
Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer PHASE2 In this study, participants with locally advanced rectal cancer patients wi...
Show More Status
Active Not Recruiting
Location
Medical Oncology,Sun Yat-sen University Cancer Center
Learn More & Join Trial
Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors PHASE1 This is a phase I/II non-randomized, open-label, single-arm, multicenter st...
Show More Status
Active Not Recruiting
Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH PHASE2 ENKTL is a highly aggressive non-Hodgkin lymphoma closely related to EBV in...
Show More Location
Department of Medical Oncology,Sun Yat-sen University Cancer Center
Learn More & Join Trial
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC PHASE3 This study is a multicenter, randomized, controlled phase III clinical tria...
Show More Location
The First Affiliated Hospital of Guangxi Medical University
Learn More & Join Trial
Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer PHASE2 This trial is a prospective, open, randomized, phase II clinical study. It ...
Show More Location
Fudan University Cancer Hospital
Learn More & Join Trial
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma PHASE2 This trial plans to enroll 40 patients with stage III-IVA (AJCC 8th, except...
Show More Location
SUN YAT-SEN UNIVERSITY cANCER CENTER
Learn More & Join Trial